medline.ch ORL Hals

	Change in diffusion weighted imaging after induction chemotherapy outperforms RECIST guideline for long-term outcome prediction in advanced nasopharyngeal carcinoma. Cancer Imaging Ai QYH, Leung HS, Mo FKF, Mao K, Wong LM, Liang YY, Hui EP, Ma BBY, King AD. PMID: 40075537 [PubMed - indexed for MEDLINE]
	Efficacy and safety of cadonilimab (PD-1/CTLA-4 bispecific) in combination with chemotherapy in anti-PD-1-resistant recurrent or metastatic nasopharyngeal carcinoma: a single-arm, open-label, phase 2 trial. BMC Med Jiang Y, Bei W, Wang L, Lu N, Xu C, Liang H, Ke L, Ye Y, He S, Dong S, Liu Q, Zhang C, Wang X, Xia W, Zhao C, Huang Y, Xiang Y, Liu G. PMID: 40069710 [PubMed - indexed for MEDLINE]
	Mechanism of skull base osteoradionecrosis explored through laboratory assessment with propensity score-matched analysis. Sci Rep Li J, Hu X, Liang T, Zhang H, Yu C. PMID: 40065029 [PubMed - indexed for MEDLINE]
	A subregional prediction model for radiation-induced hypothyroidism. BMC Med Imaging Ren W, Pan Z, Men K, Liang B, Xu Q, Yi J, Dai J. PMID: 40038595 [PubMed - indexed for MEDLINE]
	Long-term results of locoregionally advanced nasopharyngeal carcinoma treated with cisplatin and 5-fluorouracil induction chemotherapy with or without docetaxel in young and middle aged adults. J Cancer Res Clin Oncol Zheng Y, Xue F, Ou D, Niu X, Hu C, He X. PMID: 40035865 [PubMed - indexed for MEDLINE]
	Multiparameter diagnostic model using S100A9, CCL5 and blood biomarkers for nasopharyngeal carcinoma. Sci Rep Long L, Tao Y, Yu W, Hou Q, Liang Y, Huang K, Luo H, Yi B. PMID: 40033021 [PubMed - indexed for MEDLINE]
	Predicting disease progression from the rate of bodyweight change in nasopharyngeal carcinoma patient during radiotherapy. Sci Rep Sun J, Lam SKE, Teng X, Zhang J, Lee FK, Yip CW, Chow JC, Lee VH, Sun Y, Cai J. PMID: 40032903 [PubMed - indexed for MEDLINE]
	Plasma cfDNA VILL gene methylation as a diagnostic marker for nasopharyngeal carcinoma. Clin Epigenetics Fu XY, Zhou ZY, Yang TY, Wen YJ, Liu DB, Zhou YB, Yue Y, Ye F, Huang ZX. PMID: 40016817 [PubMed - indexed for MEDLINE]
	Induction chemotherapy plus camrelizumab combined with concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma in non-endemic areas: a phase 2 clinical trial in North China. BMC Med Wang Z, Sun Y, Wang Q, Chai Y, Sun J, Zhang X, Wang Q, Wang W, Wang P. PMID: 40016735 [PubMed - indexed for MEDLINE]
	Prognostic value of prognostic nutritional index in patients with nasopharyngeal carcinoma treated with endostar and concurrent chemoradiotherapy. Support Care Cancer Song J, Liu T, Huang Q, Lv Y, Wen Y, Wang R, Bie J. PMID: 40011250 [PubMed - indexed for MEDLINE]
	Multi-Omics Characterization of Genome-Wide Abnormal DNA Methylation Reveals FGF5 as a Diagnosis of Nasopharyngeal Carcinoma Recurrence After Radiotherapy. Biomolecules Long ZQ, Ding R, Quan TQ, Xu R, Huang ZH, Wei D, Zheng WH, Sun Y. PMID: 40001587 [PubMed - indexed for MEDLINE]
	Deformable registration for nasopharyngeal carcinoma using adaptive mask and weight allocation strategy based CycleFCNs model. Radiat Oncol Guo Y, Chen J, Lu L, Qiu L, Lan L, Guo F, Hong J. PMID: 40001040 [PubMed - indexed for MEDLINE]
	Early Prediction of Death Risk in Progressive Nasopharyngeal Carcinoma Using Radiomics Nomogram Based on Clinical Semantic Multi-Parameter Magnetic Resonance Imaging. Br J Hosp Med (Lond) Xi Y, Ding Y, Zhang Y, Wang M, Wu C, Chen X, Ruan L, Ding Z, Jiang F, Liu M. PMID: 39998133 [PubMed - indexed for MEDLINE]
	Pretreatment FDG PET in prognosis of locoregionally advanced nasopharyngeal carcinoma treated with intensity-modulated radiation therapy. Int J Med Sci Niu X, Xue F, Ou D, Zheng Y, Hu C, Shen C, He X. PMID: 39991768 [PubMed - indexed for MEDLINE]
	The Effect of Rabdosia rubescens on Radiotherapy-Induced Oral Mucositis in Nasopharyngeal Carcinoma Patients: A Phase II Clinical Study. Integr Cancer Ther Li L, Huang Y, Yin J, Xu P, Lan M, Li C, Qi Y, Xu K, Li B, Luo Y, Jiang Q, Peng S, Lang J, Feng M. PMID: 39989264 [PubMed - indexed for MEDLINE]
	Financial toxicity-related factors in patients with nasopharyngeal carfcinoma: a cross-sectional study. Support Care Cancer Luo Q, Chen X, Liu L, Peng J, Tang F. PMID: 39969642 [PubMed - indexed for MEDLINE]
	Validation and development of a refined M1 category for nasopharyngeal carcinoma based on the version-nine of AJCC/UICC TNM staging system in the immunotherapy era: A multicenter cohort study. Eur J Cancer Xu H, Hu Y, Xie T, Lu L, Yan Z, Chen X, Zhu L, Xie C, Lu T, Li J, Pan J, Lin S, Gong X, Guo Q. PMID: 39954311 [PubMed - indexed for MEDLINE]
	Improving Radiotherapy Plan Quality for Nasopharyngeal Carcinoma With Enhanced UNet Dose Prediction. Cancer Med Jian J, Yuan X, Xu L, Gong C, Gong X, Zhang Y. PMID: 39953816 [PubMed - indexed for MEDLINE]
	CT features of confirmed nasopharyngeal stenosis in 12 cats. J Feline Med Surg Kang K, Brash R. PMID: 39943866 [PubMed - indexed for MEDLINE]
	Anti-LAG-3 antibody LBL-007 plus anti-PD-1 antibody toripalimab in advanced nasopharyngeal carcinoma and other solid tumors: an open-label, multicenter, phase Ib/II trial. J Hematol Oncol Chen G, Sun DC, Ba Y, Zhang YX, Zhou T, Zhao YY, Zhao HY, Fang WF, Huang Y, Wang Z, Deng C, Hu DS, Wang W, Lin JG, Li GL, Luo SX, Fu ZC, Zhu HS, Wang HL, Cai SL, Kang XQ, Zhang L, Yang YP. PMID: 39920751 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 8456

Seite 1 von 423

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung